Survival analysis also showed that HCC patients with high expression of ACACA, CHEK1, TPM3, or UFC1 had poorer survival compared to those with low expressions (p = 0.011, p < 0.0001, p = 0.029, and p = 0.0043 respectively) (Fig. 7D). The gene discussed is CHEK1; the disease is hepatocellular carcinoma.